Böhm P, Kröber S, Greschniok A, Laniado M, Kaiserling E
Department of Orthopaedic Surgery, Eberhard-Karls-Universität, Tübingen, Germany.
Cancer. 1996 Sep 1;78(5):1011-23. doi: 10.1002/(SICI)1097-0142(19960901)78:5<1011::AID-CNCR11>3.0.CO;2-5.
Desmoplastic fibroma (DF) is an extremely rare bone tumor. The recommendations for therapy are often based on limited personal experience, and the rate of local recurrence in the published cases is very high. Therefore, an analysis of treatment results of published cases was performed. Furthermore, DNA analysis of the tumors from two patients was also performed.
The clinical, radiologic, and histologic data of two patients with DF of the long bones are presented. DNA flow cytometry was performed on both DFs, three cases of abdominal fibromatosis, and three cases of extraabdominal fibromatosis. One hundred eighty-nine patients analyzed in the literature and our own 2 patients were evaluated with regard to epidemiologic, clinical, and histologic data, with particular emphasis on treatment results.
DNA analysis of the locally infiltrating tumors revealed indices of proliferation between 21.5% and 24%, noticeably elevated values in comparison with extraosseous desmoid tumors (8.04%). Magnetic resonance imaging (MRI) was most valuable for imaging the intraosseous and extraosseous extent of DF. The evaluation of 191 patients (189 from the literature, 2 of the authors) showed the numbers of males and females to be equivalent, with a mean age of 23 years. DF has been reported in almost all bones, with a tendency to occur in the mandible and the long bones. Approximately 12% of patients presented with a pathologic fracture (20 of 161 patients). Infiltrative growth in the soft tissue was documented in 48% of patients. Three patients developed metastases after local recurrence. Analyzing the treatment results, the authors found a recurrence rate of 55-72% after nonresection procedures, and 17% after resection. No recurrences are reported after resection with wide surgical margins. The recurrence rate of tumors of the extremities was 55%, and 25% of these patients eventually required an amputation.
Considering the "semimalignant" character of this entity and the poor treatment results in patients with recurrent tumors, marginal or wide resection for primary treatment is recommended. The superior imaging quality of MRI greatly facilitates preoperative planning.
促结缔组织增生性纤维瘤(DF)是一种极其罕见的骨肿瘤。治疗建议通常基于有限的个人经验,且已发表病例中的局部复发率非常高。因此,对已发表病例的治疗结果进行了分析。此外,还对两名患者的肿瘤进行了DNA分析。
介绍了两名长骨DF患者的临床、放射学和组织学数据。对两例DF、三例腹壁纤维瘤病和三例腹壁外纤维瘤病进行了DNA流式细胞术检测。对文献中分析的189例患者和我们自己的2例患者的流行病学、临床和组织学数据进行了评估,特别关注治疗结果。
对局部浸润性肿瘤的DNA分析显示增殖指数在21.5%至24%之间,与骨外硬纤维瘤(8.04%)相比明显升高。磁共振成像(MRI)对显示DF的骨内和骨外范围最有价值。对191例患者(189例来自文献,2例为作者的患者)的评估显示,男女数量相当,平均年龄为23岁。几乎所有骨骼均有DF报道,以下颌骨和长骨发病倾向。约12%的患者出现病理性骨折(161例患者中的20例)。48%的患者记录有软组织浸润性生长。3例患者在局部复发后发生转移。分析治疗结果,作者发现非切除手术后复发率为55 - 72%,切除术后为17%。广泛手术切缘切除后未报告复发。四肢肿瘤的复发率为55%,其中25%的患者最终需要截肢。
考虑到该实体的“半恶性”特征以及复发肿瘤患者的治疗效果不佳,建议采用边缘或广泛切除进行初始治疗。MRI卓越的成像质量极大地有助于术前规划。